Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 4 II, 1999, Pages 369-375

  Durfy, Sharon J ^a,d   Bowen, Deborah J ^b,c   McTiernan, Anne ^c   Sporleder, Jen ^c   Burke, Wylie ^a,b,c  

^a Dept of Medical History and Ethics ^*  (United States)

^b Schools of Medicine and Public Health   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CANCER SUSCEPTIBILITY; CONFIDENTIALITY; CONTROLLED STUDY; DECISION MAKING; DISEASE ASSOCIATION; DISTRESS SYNDROME; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PATIENT ATTITUDE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT;

EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

ADULT; AFRICAN AMERICANS; ATTITUDE TO HEALTH; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOMOSEXUALITY, FEMALE; HUMANS; JEWS; MIDDLE AGED; OVARIAN NEOPLASMS; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; WASHINGTON;

EID: 0032961907     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Biesecker, B. B., Boehnke, M., Calzone, K., Markel, D. S., Garber, J. E., Collins, F. S., and Weber, B. L. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. J. Am. Med. Assoc., 269: 1970-1974, 1993.
2. Lerman, C., Daly, M., Masny, M., and Balshem, A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J. Clin. Oncol., 12: 843-850, 1994.
3. Lerman, C., Seay, J., Balshem, A., and Audrain, J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am. J. Med. Genet., 57. 385-392, 1995.
4. Struewing, J. P., Lerman, C., Kase, R. G., Giambarresi, T. R., and Tucker, M. A. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol. Biomark. Prev., 4: 169-173, 1995.
5. Wonderlick, A. L., and Fine, B. A. Knowledge of breast cancer genetics among breast cancer patients and first-degree relatives of affected individuals. J. Genet. Counseling, 6: 111-130, 1997.
6. Chaliki, H., Loader, S., Levenkron, J. C., Logan-Young, W., Hall, W. J., and Rowley, P. T. Women's receptivity to testing for a genetic susceptibility to breast cancer. Am. J. Public Health, 85: 1133-1135, 1995.
7. Richards, C. S., Ward, P. A., Roa, B. B., Friedman, L. C., Boyd, A. A., Kuenzli, G., Kunn, J. K., and Plon, S. E. Screening for 185delAG in the Ashkenazim. Am. J. Hum. Genet., 60: 1085-1098, 1997.
8. Bernhardt, B. A., Geller, G., Strauss, M., Helzlsouer, K. J., Stefanek, M., Wilcox, P. M., and Holtzman, N. A. Toward a model informed consent process for BRCA1 testing: a qualitative assessment of women's attitudes. J. Genet. Counseling, 6: 207-222, 1997.
9. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulrnore, C., Snyder, C., Lemon, S. J., Conway, T., Tonin, P., Lenoir, G., and Lynch, H. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcome. J. Am. Med. Assoc., 275; 1885-1892, 1996.
10. Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., and Brody, L. C. The carrier frequency of the BRCA1 185delAG mutation is approximately 1% in Ashkenazi Jewish individuals. Nat. Genet., 11: 198-200, 1995.
11. Haynes, S. Are lesbians at higher risk for breast cancer? Paper presented at the Workshop on Lesbians and Cancer, Fred Hutchinson Cancer Research Center, 1994.
12. Ries, L. A. G., Miller, B. A., Hankey, B. F., Kosary, C. L., Haïras, A., and Edwards, K. (eds). SEER Cancer Statistics Review 1973-1991: Tables and Graphs, NCI, NIH Pub. No. 94-2789. Bethesda, MD: National Cancer Institute, NIH, 1994.
13. Bawen, D. J., Hickman, K. M., and Powers. D. Importance of psychological variables in understanding risk perceptions and breast cancer screening for African-American women. Women's Health: Research on Gender, Behavior, and Policy, 3: 227-242, 1997.
14. Parent, M. E., Ghardidian, P., Lacroix, A., and Perret, C. The reliability of recollections of family history: implications for the medical provider. J. Cancer Ed., 12: 114-120, 1997.
15. Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C. and Mulvihill, J. J. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl. Cancer Inst., 81: 1879-1886, 1989.
16. Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., and Boyce, A. Psychological side effects of breast cancer screening. Health Psych., 10: 259-267, 1991.
17. Tambor, E. S., Bernhardt, B. A., Chase, G. A., Faden, R. R., Geller, G., Hofman, K. H., and Holtzman, N. E. Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. Am. J. Hum. Genet., 55: 626-637, 1994.
18. Smith, B. L., Gadd, M. A., Lawler, C., MacDonald, D. J., Grudberg, S. C., Chi, F S., Carlson, K., Comegno, A., and Souba, W. W. Perception of breast cancer risk among women in breast center and primary care settings: correlation with age and family history of breast cancer. Surgery, 120: 297-303, 1996.
19. Black, W. C., Nease, R. F., and Tosteson, A. N. A. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J. Natl Cancer Inst., 87: 720-731, 1995.
20. Miller, S. M., Shoda, Y., and Hurrley, K. Applying cognitive-social theory to health-protective behavior: breast self examination in cancer screening. Psychol. Bull., 119: 70-94, 1996.
21. Champion, V. L. The relationship of selected variables to breast cancer detection behaviors in women 35 and older. Ducol Nurs. Forum. 18: 733-739, 1991.
22. McCaul, K. D., Branstetter, A. D., Schroeder, D. M., and Glasgow, R. E. What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psych., 15: 423-429, 1996.
23. Newman, B., Mu, H., Butler, L. M., Millikan, R. C., Moorman, P. G., and King. M. C. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. J. Am. Med. Assoc., 279: 915-921, 1998.
24. Mastromauro, C., Myers, R. H., and Berkman, B. Attitudes toward presymptomatic testing in Huntington disease. Am. J. Med. Genet., 26: 271-282, 1987.
25. Meissen, G. J., and Berchek, R. L. Intended use of predictive testing by those at risk for Huntington disease. Am. J. Med. Genet., 26: 283-293, 1987.
26. Markel, D. S., Young, A. B., and Penney, J. B. At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan. Am. J. Med. Genet., 26: 295-305, 1987.
27. Quaid, K. A., Brandt, J., Faden, R. R., and Folstein, S. E. Knowledge, attitude and the decision to be tested for Huntington's disease. Clin. Genet., 36: 431-438, 1989.
28. Babul, R., Adam, S., Kremer, B., Dufrasne, S., Wiggins, S., Huggins, M., Theilman, J., Bloch, M., Hayden, M., for the Canadian Collaborative Group on Predictive Testing for Huntington Disease. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. J. Am. Med. Assoc., 270: 2321-2325, 1993.
29. Lynch, H. T., Watson, P., Conway, T. A., Lynch, J. A., Slominski-Caster, S. M., Narod, S. A., Feunteun, J., and Lenoir, F. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Arch. Intern. Med., 153: 1979-1987, 1993.
30. Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J. F., Lynch, P., McTiernan, A., Offit, K., Perlman, J., Petersen, G., Thomson, F., and Varricchio, C. for the Cancer Genetic Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. J. Am. Med. Assoc., 277: 997-1003, 1997.
31. Croyle, R. T., Smith, K. R., Botkin, J. R., Baty, B., and Nash, J. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psych., 16: 63-72, 1997.
32. Lerman, C., Biesecker, B., Benkendorf, J. L., Kerner, J., Gomez-Caminero, A., Hughes, C., and Reed, M. M. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J. Natl. Cancer Inst., 89: 148-157, 1997.